Jim J. Collins, Ph.D.

Termeer Professor of Medical Engineering & Science at MIT

Institute Member, Broad Institute of MIT and Harvard

Synthetic Biology, Systems Biology

EDUCATION

BA – College of the Holy Cross

PhD – University of Oxford

AWARDS AND ACCOLADES

Rhodes Scholar at Oxford University, 1987-1990

The MacArthur ‘Genius’ Award, 2003

National Academy of Medicine, 2012

National Academy of Sciences, 2014

National Academy of Engineering, 2011

National Advisory Council for Human Genome Research

Institute of Medicine of the National Academy of Sciences

Presidential Commission for the Study of Bioethical Issues, Appointed by President Barack Obama, 2010

COMPANIES AND BOARDS

Co-Founder: Synlogic (NASDAQ: SYBX), Senti Biosciences, Sherlock Biosciences, Cellarity

Board of Directors: Fulcrum Therapeutics (NASDAQ: FULC), Sherlock Biosciences, Cellarity

Scientific Advisory Board: Danaher Corporation (NYSE: DHR), Synlogic (NASDAQ: SYBX), Senti Biosciences, Shape Therapeutics

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.